Verition Fund Management
PROK icon

Verition Fund Management’s ProKidney PROK Stock Holding History

Verition Fund Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,603
Closed -$132K – 2607
2022
Q3 		$132K Sell
14,603
-6,797
-32% -$59.1K ﹤0.01% 2575
2022
Q2 		$213K Hold
21,400
– – ﹤0.01% 1909
2022
Q1 		$211K Hold
21,400
– – ﹤0.01% 2326
2021
Q4 		$212K Hold
21,400
– – ﹤0.01% 2221
2021
Q3 		$210K Buy
+21,400
New +$211K ﹤0.01% 1598

Other funds holding PROK

SCG
Social Capital Group Menlo Park, California $5.16M AUM 66.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $112M AUM 3.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Verition Fund Management's PROK Position: Q4 2022 in Review

Verition Fund Management sold out of ProKidney (PROK) in Q4 2022, closing a stake of 14,603 shares — an estimated $132K sold.

Verition Fund Management first reported a position in PROK in Q3 2021 and held it in 5 quarters. The position peaked at $213K in Q2 2022. 27 funds tracked by Wall St. Rank hold PROK as of Q4 2022.

  • Verition Fund Management reported no remaining ProKidney position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 14,603 ProKidney shares in Q4 2022, an estimated $132K.
  • Verition Fund Management first reported a position in ProKidney in Q3 2021 and held it in 5 quarters.
  • Verition Fund Management's ProKidney position peaked at $213K in Q2 2022.
  • 27 funds tracked by Wall St. Rank held ProKidney as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.